Photoelectrochemical immunoassay for the breast cancer biomarkers CA 15-3 based on In2O3/ZnIn2S4 heterojunction

Jiajie Xue,Lingjun Kong,Wei Lin,Jiasheng Zhang,Youzhi Zhu
DOI: https://doi.org/10.1039/d4nj00584h
IF: 3.3
2024-03-05
New Journal of Chemistry
Abstract:The development of sensitive breast cancer biomarkers (CA15-3) measurement techniques is of great significance for the early diagnosis and therapeutic monitoring of breast cancer worldwide. Here, we have designed a split-type photoelectrochemical (PEC) immunoassay platform for the ultrasensitive determination of CA15-3 using In2O3/ZnIn2S4 heterojunction with high photovoltaic conversion performance as a photoactive substrate. Efficient photocurrent responsive In2O3/ZnIn2S4 was formed by surface loading narrow bandgap ZnIn2S4 on MOF-derived wide bandgap In2O3 nanomaterials. Subsequently, a sandwich immunoreaction is performed using an alkaline phosphatase (ALP)-labeled secondary antibody as a signaling indicator to produce large amounts of ascorbic acid by enzymatic biocatalysis. Since ascorbic acid is an excellent electron donor capable of promoting photogenerated electron separation in semiconductor materials, thus enhances the anodic photocurrent of In2O3/ZnIn2S4-modified electrode. Under the optimal catalyst loading and immunoreaction time, the In2O3/ZnIn2S4-based PEC immunoassay showed a good photocurrent response to CA15-3 over a wide detection range from 1.0 mU/mL to 10000 mU/mL with a limit of detection of 0.45 mU/mL. Thanks to the excellent photocurrent response of In2O3/ZnIn2S4 to ascorbic acid and the split-type immunoassay protocol, the constructed PEC immunosensing platform has the advantages of high-precision, anti-interference, and acceptable accuracy, and the results are equivalent to those of commercial enzyme-linked immunosorbent assay (ELISA) kits.
chemistry, multidisciplinary
What problem does this paper attempt to address?